Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents (2024)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; CARVALHO, MARIA FERNANDA LOPES - ICB ; ALMEIDA, BRUNA OLIVEIRA DE - ICB ; VICARI, HUGO PASSOS - ICB ; LIMA, KELI CRISTINA DE - FM
- Unidades: FM; ICB
- DOI: 10.1016/j.htct.2023.11.007
- Assunto: FARMACOLOGIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Sao José do Rio Preto, SP
- Date published: 2024
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1387
- Volume/Número/Paginação/Ano: v. 46, n. 3, p. 273-282, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CARVALHO, Maria Fernanda Lopes et al. Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents. Hematology, Transfusion and Cell Therapy, v. 46, n. 3, p. 273-282, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2023.11.007. Acesso em: 10 fev. 2026. -
APA
Carvalho, M. F. L., Almeida, B. O. de, Bueno, M. L. P., Vicari, H. P., Lima, K., Rego, E. M., et al. (2024). Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents. Hematology, Transfusion and Cell Therapy, 46( 3), 273-282. doi:10.1016/j.htct.2023.11.007 -
NLM
Carvalho MFL, Almeida BO de, Bueno MLP, Vicari HP, Lima K, Rego EM, Roversi FM, Machado Neto JA. Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 3): 273-282.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.htct.2023.11.007 -
Vancouver
Carvalho MFL, Almeida BO de, Bueno MLP, Vicari HP, Lima K, Rego EM, Roversi FM, Machado Neto JA. Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 3): 273-282.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.htct.2023.11.007 - Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes
- Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells
- Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms
- New molecular targets in acute leukemias: cytoskeletal regulatory proteins
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- CDC7 (cell division cycle 7)
- Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia
Informações sobre o DOI: 10.1016/j.htct.2023.11.007 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Comprehensive_analysis_of... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
